HealthCare Institute of New Jersey Announces New Board and Steering Committee Leadership
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
Alex Kelly, who is Executive Vice President, Corporate Affairs, Allergan, has been elected Chair of the HINJ Board of Trustees. He previously served as Treasurer.
Mr. Kelly has been an EVP and the Chief Communications Officer at Allergan since 2015. Previously, he served as Senior Vice President, Chief Integration Officer since July 2014. In this role, he led the integration of Forest Laboratories and co-led the integration of Allergan, Inc. following Actavis’ acquisition of each company. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. Previously, Mr. Kelly served as Vice President, Investor Relations at Bausch + Lomb and he was Senior Vice President, Investor Relations at Merck & Co., Inc. He earned his Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude.
Mr. Kelly succeeds Yin Becker, Vice President, Communications and Public Affairs, Stryker. Ms. Becker continues to serve HINJ as Immediate Past Chair.
Also at its May 15 meeting, the HINJ Board elected Dan Casserly, U.S. Country Head, Government Affairs, Novartis Services, Inc., to serve as Vice Chair. The new Treasurer is Steven Immergut, Vice President and Head of Communications and Advocacy Relations, Pharmaceuticals, Bayer. Lisa M. Goldman continues to serve as Board Secretary.
HINJ also has announced that Loredana Cromarty, Associate Vice President, Government Affairs, Allergan, has been appointed Chair of the HINJ Steering Committee. The new Vice Chair is Wendy Lazarus, Director, State Government Relations, Pfizer, Inc.
HINJ Co-Sponsors New Jersey Health Care Stakeholders Summit
More than 100 professionals attended the New Jersey Health Care Stakeholders Summit held on April 27 at the New Jersey Hospital Association (NJHA) headquarters in Princeton.
The day-long event was co-sponsored by HINJ, the Medical Society of New Jersey (MSNJ), the New Jersey Association of Health Plans (NJAHP) and NJHA. Participants included representatives of HINJ member companies and the sponsor organizations, along with policymakers, health care stakeholders, patient representatives, business leaders and journalists.
Dr. Harold Paz, Chief Medical Officer of Aetna, deliver the keynote presentation. The morning panel discussion provided “An Environmental Assessment of Healthcare: Where We’re Going Nationally.” The panelists were from America’s Health Insurance Plans, the American Hospital Association, the American Medical Association and PhRMA.
The afternoon topic, “New Jersey’s Health Care Ecosystem: Impacts to Our Home State,” was discussed by a panel of association presidents composed of Cathleen Bennett of NJHA, Larry Downs of MSNJ, Dean Paranicas and Wardell Sanders of NJAHP.
CIANJ & HINJ Thank Rep. Gottheimer for His Support of the Medical Device Tax Suspension
January 25, 2018, Paramus – HINJ President and CEO Dean J. Paranicas (right) expressed appreciation to Rep. Josh Gottheimer (at podium) during today’s event for his vote to suspend the innovation-stifling, job-threatening medical device tax. CIANJ President Anthony Russo (left), who hosted the event, also spoke.
HINJ President and CEO Participates in Panel on ACA
Dean Paranicas participated in a February 23 panel discussion sponsored by the Chamber of Commerce Southern New Jersey (CCSNJ) on “The Future of Health Care and the ACA,” which was part of the Chamber’s “Make New Jersey Competitive” series. The event, which was held at the Hotel ML in Mt. Laurel, drew nearly 150 attendees.
HINJ President Testifies at Inaugural Hearing of Assembly Science, Innovation and Technology Committee
Trenton, February 1, 2018 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), testified today (Feb. 1) at the inaugural hearing of the Assembly Science, Innovation and Technology Committee.
Paranicas said the panel will play a valuable role by focusing on the needs of New Jersey’s innovation economy, “which has a long legacy as a global leader spanning more than a century in chemicals, pharmaceuticals, telecommunications and food processing, all of which have their roots here.”
The state has made tremendous progress to foster innovation and research in recent years, he said, but more needs to be done. Along with offering specific recommendations, the HINJ President said: “A state’s attitude goes a long way in setting the tone. In our case, New Jersey needs to embrace the life sciences as Texas embraces oil and gas and Michigan embraces the automobile industry.”
Paranicas commended Assembly Speaker Craig Coughlin for establishing the committee and expressed appreciation to Assemblyman Andrew Zwicker for agreeing to serve as Chairman and to the Committee members for their participation.
The full text of Paranicas’ testimony is posted on the HINJ website here.
‘Women in STEM: Med-Tech Innovators’ on February 27, panel discussion sponsored by HINJ and Rutgers’ Medical Device Development Center
Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, February 27 for “Women in STEM: Med-Tech Innovators,” the fourth in the Rutgers-HINJ 2017-2018 series of educational panels and seminars that focus on the medical device industry.
The event, which will be held from 4:00 to 6:00 p.m. at Rutgers University’s Fiber Optics Auditorium on Busch Campus in Piscataway, will include a panel discussion on industry careers for women in STEM.
Among the speakers will be…
- Theresa Scheuble, Director of R&D, Janssen;
- Marion van Werven-Franssen, Senior Director, Continuous Improvement and Innovation, Janssen; and
- Janet Burpee, CEO, Burpee Medsystems.
There is no cost to attend but online registration is required.
HINJ Media Contact:
Edward F. Tate III
Director of Communications
732-729-9619, ext. 344